Oklo, a nuclear stock, has seen a 275% gain in 2025 but is still pre-revenue and early in development. Valued at $12 billion, it’s being treated as if ready to deploy reactors, while NuScale Power, already approved, is valued at $5 billion. Oklo’s rich valuation, challenges with uranium supply, and licensing timelines make it risky. The DOE expects commercial reactors in the 2030s. Consider caution and watch for disappointment. The Motley Fool doesn’t recommend Oklo, citing a valuation that leaves little room for error. Proceed with care or consider other investments.

Read more at Yahoo Finance: Here’s Why I Wouldn’t Touch Oklo With a 10-Foot Pole